SHR-2042 is a selective agonist of the GLP-1 receptor. By activating the GLP-1 receptor, it enhances insulin secretion and suppresses glucagon secretion, thereby improving blood sugar regulation. When combined with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), it forms micelles that promote monomerization, increasing oral absorption efficiency.
Formula:
C205H314N48O63
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
